PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinomaXian-De Liu, Eric Jonasch|Nature Communications|2020Cited by 173
SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell CarcinomaXian-De Liu, Eric Jonasch|Clinical Cancer Research|2023Cited by 13